Pharmacokinetic and pharmacodynamic properties of once-weekly insulin icodec in individuals with type 1 diabetes.

Ulrike HoevelmannSusanne EngbergTim HeiseNiels Rode KristensenLea NørgreenEric ZijlstraRasmus Ribel-Madsen

Published in: Diabetes, obesity & metabolism (2024)

The pharmacokinetic/pharmacodynamic properties of icodec suggest its potential to provide basal coverage in a basal-bolus insulin regimen in people with T1D.

Keyphrases

type diabetes
glycemic control
healthcare
affordable care act
skeletal muscle
adipose tissue
insulin resistance
weight loss